Inventor · disambiguated record
Gunther Berndl
Also filed as: BERNDL GUNTHER
27 granted patents·14 pending applications·421 citations·filing 1998–2018
97Inventor score
Top patents by PatentIndex Score
41 records- 0195US8268349B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2012·Granted Sep 18, 2012·15 cites·7 claims
- 0293US6599528B1Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substancesABBOTT GMBH & CO KG·Filed 2000·Granted Jul 29, 2003·50 cites·6 claims
- 0391US7419685B2Process for producing solid dosage formsBASF AG·Filed 2005·Granted Sep 2, 2008·7 cites·6 claims
- 0489US8377952B2Solid pharmaceutical dosage formulationABBOTT LAB·Filed 2005·Granted Feb 19, 2013·4 cites·35 claims
- 0588US8399015B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2011·Granted Mar 19, 2013·3 cites·31 claims
- 0688US8025899B2Solid pharmaceutical dosage formABBOTT LAB·Filed 2004·Granted Sep 27, 2011·14 cites·14 claims
- 0788US6528089B1Method for producing solid dosing formsBASF AG·Filed 1998·Granted Mar 4, 2003·70 cites·20 claims
- 0884US8691878B2Solid pharmaceutical dosage formABBVIE INC·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 0983US9060936B2Dosage forms with improved bioavailabilityBERNDL GUNTHER·Filed 2011·Granted Jun 23, 2015·4 cites·31 claims
- 1082US8333990B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2010·Granted Dec 18, 2012·1 cites·23 claims
- 1182US6497867B2Use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizersBASF AG·Filed 2001·Granted Dec 24, 2002·10 cites·5 claims
- 1279US9414992B2Process for producing a solid dispersion of an active ingredientABBOTT GMBH & CO KG·Filed 2013·Granted Aug 16, 2016·3 cites·28 claims
- 1379US6632389B1Underwater or under-hydrocarbon pelletizing of biologically-active-compound-containing meltsBASF AG·Filed 2000·Granted Oct 14, 2003·16 cites·9 claims
- 1478US8486456B2Itraconazole compositions with improved bioavailabilityBERNDL GUNTHER·Filed 2006·Granted Jul 16, 2013·2 cites·13 claims
- 1576US6322816B1Fast-acting analgesicBASF AG·Filed 1998·Granted Nov 27, 2001·46 cites·10 claims
- 1676US6284803B1Solid dosage form with polymeric binderBASF AG·Filed 1999·Granted Sep 4, 2001·44 cites·4 claims
- 1776US6075107AUse of copolymers of N-vinylprrolidone in preparations of water-insoluble substancesBASF AG·Filed 1998·Granted Jun 13, 2000·46 cites·39 claims
- 1873US8470347B2Self-emulsifying active substance formulation and use of this formulationBERNDL GUNTHER·Filed 2001·Granted Jun 25, 2013·3 cites·29 claims
- 1973US7846477B2Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrierABBOTT GMBH & CO KG·Filed 2003·Granted Dec 7, 2010·7 cites·22 claims
- 2073US6787157B1Multiphase active ingredient-containing formulationsABBOTT LAB·Filed 1998·Granted Sep 7, 2004·39 cites·4 claims
- 2172US2014179721A1Solid pharmaceutical dosage formABBVIE INC·Filed 2014·Application pending·0 cites
- 2271US7906144B1Solubilizing aids in powder form for solid pharmaceutical presentation formsBASF AG·Filed 2000·Granted Mar 15, 2011·2 cites·13 claims
- 2371US2008299203A1Solid Pharmaceutical Dosage FormulationROSENBERG JOERG·Filed 2008·Application pending·0 cites
- 2467US2014135388A1Self-Emulsifying Active Ingredient Formulation and the Use of This FormulationABBVIE INC·Filed 2013·Application pending·0 cites
- 2565US8309613B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2010·Granted Nov 13, 2012·0 cites·18 claims
- 2663US2007249643A1Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2007·Application pending·0 cites
- 2762US7022344B1Process for producing solid dosage formsBASF AG·Filed 1999·Granted Apr 4, 2006·20 cites·10 claims
- 2862US6689299B2Process for producing solid creatine dosage forms and dosage forms obtainable therebyBASF AG·Filed 2001·Granted Feb 10, 2004·1 cites·9 claims
- 2962US2012225953A1Self-Emulsifying Active Ingredient Formulation and the Use of this FormulationBERNDL GUNTHER·Filed 2012·Application pending·0 cites
- 3062US2013004578A1Solid Pharmaceutical Dosage FormulationABBVIE INC·Filed 2012·Application pending·0 cites
- 3160US2009028938A1Dosage forms with improved bioavailabilityABBOTT GMBH & CO KG·Filed 2006·Application pending·0 cites
- 3259US2009302493A1Process for producing a solid dispersion of an active ingredientABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 3359US2011123652A1Self-emulsifying active substance formulation and use of this formulationBERNDL GUNTHER·Filed 2010·Application pending·0 cites
- 3457US2008181948A1Solid pharmaceutical dosage formulationsABBOTT LAB·Filed 2007·Application pending·0 cites
- 3557US2018185287A1Formulation Obtained from a Powder Mixture Comprising an Inorganic PigmentABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3657US2008107733A1Formulation Obtained From A Powder Mixture Comprising An Inorganic PigmentFASTNACHT KATJA·Filed 2005·Application pending·0 cites
- 3752US6331294B1Use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizersBASF AG·Filed 1999·Granted Dec 18, 2001·12 cites·9 claims
- 3848US9149431B2Itraconazole compositions with improved bioavailabilityABBOTT GMBH & CO KG·Filed 2013·Granted Oct 6, 2015·0 cites·11 claims
- 3945US2004029892A1Compositions and dosage forms for application in the oral cavity in the treatment of mykosesFiled 2001·Application pending·0 cites
- 4044US2005048112A1Solid pharmaceutical dosage formFiled 2003·Application pending·0 cites
- 4139US10463739B2Solid retard formulations based on solid dispersionsBERNDL GUNTHER·Filed 2011·Granted Nov 5, 2019·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →